CN101132766A - 含有类固醇激素的片剂 - Google Patents

含有类固醇激素的片剂 Download PDF

Info

Publication number
CN101132766A
CN101132766A CNA2006800071551A CN200680007155A CN101132766A CN 101132766 A CN101132766 A CN 101132766A CN A2006800071551 A CNA2006800071551 A CN A2006800071551A CN 200680007155 A CN200680007155 A CN 200680007155A CN 101132766 A CN101132766 A CN 101132766A
Authority
CN
China
Prior art keywords
drug delivery
delivery system
steroid hormone
steroid
ment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800071551A
Other languages
English (en)
Chinese (zh)
Inventor
M·克鲁米
A·拉德梅尔
S·格内尔
M·迪特根
K·延森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Bayer CropScience AG
Original Assignee
Bayer Schelling Pharmaceuticals
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36998911&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN101132766(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schelling Pharmaceuticals, LTS Lohmann Therapie Systeme AG filed Critical Bayer Schelling Pharmaceuticals
Priority to CN201510393577.8A priority Critical patent/CN104983669B/zh
Publication of CN101132766A publication Critical patent/CN101132766A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2006800071551A 2005-03-31 2006-03-15 含有类固醇激素的片剂 Pending CN101132766A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510393577.8A CN104983669B (zh) 2005-03-31 2006-03-15 含有类固醇激素的片剂

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005015128A DE102005015128B4 (de) 2005-03-31 2005-03-31 Wafer enthaltend Steroidhormone
DE102005015128.0 2005-03-31

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201510393577.8A Division CN104983669B (zh) 2005-03-31 2006-03-15 含有类固醇激素的片剂

Publications (1)

Publication Number Publication Date
CN101132766A true CN101132766A (zh) 2008-02-27

Family

ID=36998911

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA2006800071551A Pending CN101132766A (zh) 2005-03-31 2006-03-15 含有类固醇激素的片剂
CN201510393577.8A Expired - Fee Related CN104983669B (zh) 2005-03-31 2006-03-15 含有类固醇激素的片剂

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201510393577.8A Expired - Fee Related CN104983669B (zh) 2005-03-31 2006-03-15 含有类固醇激素的片剂

Country Status (26)

Country Link
US (2) US9763960B2 (enExample)
EP (1) EP1863444B1 (enExample)
JP (2) JP5843416B2 (enExample)
KR (2) KR101428625B1 (enExample)
CN (2) CN101132766A (enExample)
AR (1) AR054245A1 (enExample)
AU (1) AU2006228820B2 (enExample)
BR (1) BRPI0609601A2 (enExample)
CA (1) CA2598892C (enExample)
CR (1) CR9468A (enExample)
DE (1) DE102005015128B4 (enExample)
DO (1) DOP2006000070A (enExample)
EA (1) EA014183B1 (enExample)
GT (1) GT200600126A (enExample)
IL (1) IL186081A0 (enExample)
MX (1) MX2007012081A (enExample)
NO (1) NO20075404L (enExample)
NZ (1) NZ592882A (enExample)
PE (1) PE20061194A1 (enExample)
SG (1) SG179459A1 (enExample)
SV (1) SV2008002466A (enExample)
TW (1) TWI393576B (enExample)
UA (1) UA92011C2 (enExample)
UY (1) UY29441A1 (enExample)
WO (1) WO2006102990A2 (enExample)
ZA (1) ZA200706116B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110709064A (zh) * 2017-06-07 2020-01-17 Lts勒曼治疗系统股份公司 具有高单位面积重量的快速崩解的泡沫体薄片

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006113505A2 (en) 2005-04-15 2006-10-26 Clarus Therapeutics, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
DE102006027796A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Estrogen-Gestagen-Kombinationen
EP2249803A2 (en) * 2008-02-13 2010-11-17 Bayer Schering Pharma Aktiengesellschaft Estradiol-containing drug delivery system
US20110052699A1 (en) * 2008-02-13 2011-03-03 Adrian Funke Drug delivery system with stabilising effect
TW201008569A (en) * 2008-08-08 2010-03-01 Bayer Schering Pharma Ag Progestin-containing drug delivery system
JP2012509286A (ja) * 2008-11-21 2012-04-19 バイエル ファーマ アクチエンゲゼルシャフト 薬物送達システム
TR201902233T4 (tr) 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
US10806703B2 (en) * 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
WO2014018075A1 (en) 2012-07-23 2014-01-30 Crayola, Llc Dissolvable films and methods of using the same
CN112020361A (zh) * 2018-02-02 2020-12-01 阿克罗斯生物制药公司 睾酮治疗方法
US11564933B2 (en) 2019-04-12 2023-01-31 Tolmar, Inc. Methods of treating testosterone deficiency

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
ES2105262T3 (es) * 1992-05-18 1997-10-16 Minnesota Mining & Mfg Dispositivo de suministro de farmaco a traves de las mucosas.
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE19847252B4 (de) * 1998-10-02 2004-02-12 Jenapharm Gmbh & Co. Kg Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030092658A1 (en) * 2001-02-02 2003-05-15 Meyers Rachel E. Novel human enzyme family members and uses thereof
AU2001273231A1 (en) * 2000-07-06 2002-01-21 Delsys Pharmaceutical Corporation Method for formulating healthcare products with enhanced stability
WO2005039531A1 (en) * 2003-10-10 2005-05-06 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
GB0100760D0 (en) * 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
JO2492B1 (en) * 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
WO2005011617A2 (en) * 2003-07-31 2005-02-10 Ivax Corporation Transmucosal dosage forms for brain-targeted steroid chemical delivery systems

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110709064A (zh) * 2017-06-07 2020-01-17 Lts勒曼治疗系统股份公司 具有高单位面积重量的快速崩解的泡沫体薄片

Also Published As

Publication number Publication date
GT200600126A (es) 2007-03-14
CA2598892A1 (en) 2006-10-05
UA92011C2 (ru) 2010-09-27
JP5843416B2 (ja) 2016-01-13
WO2006102990A3 (de) 2007-03-22
WO2006102990A2 (de) 2006-10-05
DE102005015128B4 (de) 2008-12-11
NO20075404L (no) 2007-12-20
DOP2006000070A (es) 2007-08-15
DE102005015128A1 (de) 2006-10-05
EP1863444B1 (de) 2015-12-09
SG179459A1 (en) 2012-04-27
EA014183B1 (ru) 2010-10-29
TWI393576B (zh) 2013-04-21
CA2598892C (en) 2014-10-14
JP2013155190A (ja) 2013-08-15
CR9468A (es) 2008-01-21
TW200714299A (en) 2007-04-16
UY29441A1 (es) 2006-10-31
US9763960B2 (en) 2017-09-19
NZ592882A (en) 2012-12-21
AU2006228820A1 (en) 2006-10-05
KR20140063740A (ko) 2014-05-27
MX2007012081A (es) 2007-11-21
JP2008534533A (ja) 2008-08-28
CN104983669B (zh) 2018-05-18
KR101428625B1 (ko) 2014-08-13
KR20080002798A (ko) 2008-01-04
ZA200706116B (en) 2008-11-26
IL186081A0 (en) 2008-01-20
EA200702102A1 (ru) 2008-04-28
AU2006228820B2 (en) 2011-08-25
PE20061194A1 (es) 2006-11-23
US20170348321A1 (en) 2017-12-07
US20060222708A1 (en) 2006-10-05
EP1863444A2 (de) 2007-12-12
BRPI0609601A2 (pt) 2010-04-20
CN104983669A (zh) 2015-10-21
AR054245A1 (es) 2007-06-13
SV2008002466A (es) 2008-02-08

Similar Documents

Publication Publication Date Title
US20170348321A1 (en) Wafer Comprising Steroid Hormones
US20240165032A1 (en) Drug delivery system
Attia et al. Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels
BR122022005637B1 (pt) Composição farmacêutica líquida não aquosa
EP2029099A2 (de) Antihypertonie-kombinationswafer
JP2012031164A (ja) フィルム状製剤
HK1116055A (en) Tablet containing steroid hormones
DE102006027796A1 (de) Estrogen-Gestagen-Kombinationen
KR102862769B1 (ko) 코르티코스테로이드의 점막부착성 제약 조성물
NZ618535B2 (en) Drug delivery system

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1116055

Country of ref document: HK

ASS Succession or assignment of patent right

Free format text: FORMER OWNER: BAYER INTELLECTUAL PROPERTY GMBH

Effective date: 20140808

Owner name: BAYER INTELLECTUAL PROPERTY GMBH

Free format text: FORMER OWNER: BAYER PHARMA AG

Effective date: 20140808

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: German Adner Beh

Applicant after: LTS LOHMANN THERAPIE-SYSTEME AG

Applicant after: Bayer pharmaceutical AG

Address before: German Adner Beh

Applicant before: LTS Lohmann Therapie-Systeme AG

Applicant before: Bayer Schelling Pharmaceuticals

TA01 Transfer of patent application right

Effective date of registration: 20140808

Address after: German Adner Beh

Applicant after: LTS LOHMANN THERAPIE-SYSTEME AG

Address before: German Adner Beh

Applicant before: LTS Lohmann Therapie-Systeme AG

Applicant before: BAYER CROPSCIENCE AG

Effective date of registration: 20140808

Address after: German Adner Beh

Applicant after: LTS LOHMANN THERAPIE-SYSTEME AG

Applicant after: BAYER CROPSCIENCE AG

Address before: German Adner Beh

Applicant before: LTS Lohmann Therapie-Systeme AG

Applicant before: Bayer pharmaceutical AG

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1116055

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20080227